Skip to main content

Hosseinion Warren's Form 4 filing

Nutex Health Inc. (NUTX) · filed Dec 21, 2021

Accession no.
0001486189-21-000013
Filed
Dec 21, 2021
Trade date
Mar 19, 2019-Feb 25, 2021
Filing delay
1,008 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 2 derivative transactions. It was filed 1008 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hosseinion WarrenCIK 0001438327Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 25, 2021Common StockJOtherAcquired+894,209$2.04+$1,824,186.361,151,563Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 27, 2020Common StockPPurchaseAcquired+800,000–F2–800,000Direct
Mar 19, 2019Common StockPPurchaseAcquired+21,590$6.67+$144,005.321,590Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

100,000 options at $1.50 exercise date 01/27/2020 expiration date 01/27/2030 100,000 options at $1.50 exercise date 05/11/2020 expiration date 05/11/2027 600,000 options at $1.61 exercise date 01/28/2021 expiration date 01/28/2030

Referenced by the price of 1 transaction in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)